Apellis Pharmaceuticals, Inc. (BIT:1APLS)
19.01
0.00 (0.00%)
At close: Oct 29, 2025
Apellis Pharmaceuticals Employees
As of December 31, 2024, Apellis Pharmaceuticals had 710 total employees, including 705 full-time and 5 part-time employees. The number of employees increased by 4 or 0.57% compared to the previous year.
Employees
710
Change (1Y)
4
Growth (1Y)
0.57%
Revenue / Employee
€1,223,552
Profits / Employee
€54,155
Market Cap
2.36B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 710 | 4 | 0.57% |
| Dec 31, 2023 | 706 | -61 | -7.95% |
| Dec 31, 2022 | 767 | 291 | 61.13% |
| Dec 31, 2021 | 476 | 102 | 27.27% |
| Dec 31, 2020 | 374 | 139 | 59.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Stellantis | 248,243 |
| Poste Italiane | 125,097 |
| Intesa Sanpaolo | 94,736 |
| Assicurazioni Generali | 86,851 |
| UniCredit | 75,265 |
| Leonardo S.p.a. | 60,468 |
| Enel SpA | 60,359 |
| Eni S.p.A. | 32,492 |